Dr. Luai Tabaza is an interventional cardiologist and an assistant professor of clinical cardiology at Rowan University, practicing at Virtua Health, where he serves as director of the complex higher-risk indicated procedures (CHIP) program and co-founder of the system-wide pulmonary embolism response team.

He specializes in complex coronary and peripheral interventions, including chronic total occlusion PCI and mechanical circulatory support, and is recognized for advancing multidisciplinary care and high-risk revascularization strategies. 

Dr. Tabaza is an active clinical investigator, serving as principal investigator for multiple national and international trials, with academic contributions spanning advanced endovascular therapies, robotic PCI, and vascular access strategies. 

His work reflects a focused commitment to clinical innovation, program development, and physician education, establishing him as a rising leader in interventional cardiology.